Oxford suspends dosing in trial of AstraZeneca COVID vaccine in children, teenagers
Apr 07, 2021, at 02:02 pm
London/Sputnik: The University of Oxford said it had suspended administering doses of the vaccine against the novel coronavirus disease (COVID-19) it developed with AstraZeneca in a UK study on children and teenagers aged 6-17, The Wall Street Journal (WSJ) reported.